Bioqual (OTCMKTS:BIOQ – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.76) EPS for the quarter, reports. The business had revenue of $11.77 million during the quarter. Bioqual had a return on equity of 1.23% and a net margin of 0.81%.
Bioqual Price Performance
Shares of OTCMKTS BIOQ opened at $67.50 on Friday. Bioqual has a fifty-two week low of $59.00 and a fifty-two week high of $80.00. The stock has a market capitalization of $60.75 million, a price-to-earnings ratio of 63.08 and a beta of -0.31. The business has a 50-day moving average of $68.70 and a 200-day moving average of $71.37.
Bioqual Announces Dividend
The firm also recently disclosed an annual dividend, which will be paid on Monday, October 28th. Stockholders of record on Monday, October 7th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, October 7th. This represents a dividend yield of 0.74%. Bioqual’s dividend payout ratio is 46.73%.
Bioqual Company Profile
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Further Reading
- Five stocks we like better than Bioqual
- The Role Economic Reports Play in a Successful Investment Strategy
- Talen Energy: A Nuclear Power Stock That Can Keep Winning
- Consumer Staples Stocks, Explained
- Rocket Lab Stock Soars Higher: Can It Keep Climbing?
- Using the MarketBeat Dividend Yield Calculator
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
